Veterinary Technician Specialist (Neurology) Veterinary Emergency Group Chicago, Illinois, United States
Disclosure(s):
Melissa Campo, BS, MSc, CVT, VTS (Neurology): No financial relationships to disclose
Discover the world of Meningoencephalitis of Unknown Origin (MUO) in this lecture, as we look at how this condition presents in veterinary patients. We will delve into the clinical manifestations, explore potential causative factors, and treatments, primarily focusing on cytarabine. This presentation will offer insight into cytarabine’s mechanisms of action in resolving inflammation and restoring neurological function, despite being chemotherapy.
Learning Objectives:
By the end of this lecture, participants will be able to identify and describe the diverse clinical manifestations of Meningoencephalitis of Unknown Origin (MUO) in veterinary patients, gaining a comprehensive understanding of the wide range of neurological symptoms associated with this condition.
After attending this lecture, learners will be able to analyze potential causative factors contributing to MUO in veterinary patients, and evaluate the treatment options.
By the conclusion of this presentation, attendees will have a clear grasp of the mechanisms through which cytarabine exerts its effects, particularly in the context of alleviating inflammation and facilitating neurological recovery in cases of MUO. Participants will be able to appreciate the multifaceted role of chemotherapy agents in veterinary medicine beyond their conventional applications.
